Zhejiang Hisun Pharmaceutical Co Ltd (SHG:600267) — Market Cap & Net Worth
Market Cap & Net Worth: Zhejiang Hisun Pharmaceutical Co Ltd (600267)
Zhejiang Hisun Pharmaceutical Co Ltd (SHG:600267) has a market capitalization of $1.98 Billion (CN¥13.55 Billion) as of September 16, 2026. Listed on the SHG stock exchange, this China-based company holds position #6194 globally and #1181 in its home market, demonstrating a -2.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Hisun Pharmaceutical Co Ltd's stock price CN¥11.30 by its total outstanding shares 1198761196 (1.20 Billion). Also see Zhejiang Hisun Pharmaceutical Co Ltd balance sheet assets for a full breakdown of the balance sheet.
Zhejiang Hisun Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Zhejiang Hisun Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.66 Billion to $1.98 Billion (-1.02% CAGR). Also see Zhejiang Hisun Pharmaceutical Co Ltd (600267) cash conversion ratio for how efficiently the company converts equity into cash flow.
Zhejiang Hisun Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Hisun Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 600267 stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.16x
Zhejiang Hisun Pharmaceutical Co Ltd's market cap is 0.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.21x
Zhejiang Hisun Pharmaceutical Co Ltd's market cap is 3.21 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.22 Billion | $9.73 Billion | -$94.43 Million | 0.23x | N/A |
| 2017 | $2.57 Billion | $10.57 Billion | $13.57 Million | 0.24x | 189.30x |
| 2018 | $1.43 Billion | $10.19 Billion | -$492.47 Million | 0.14x | N/A |
| 2019 | $1.69 Billion | $11.07 Billion | $93.07 Million | 0.15x | 18.12x |
| 2020 | $2.82 Billion | $11.35 Billion | $417.19 Million | 0.25x | 6.76x |
| 2021 | $2.40 Billion | $12.14 Billion | $486.89 Million | 0.20x | 4.92x |
| 2022 | $1.91 Billion | $12.04 Billion | $488.86 Million | 0.16x | 3.90x |
| 2023 | $1.64 Billion | $10.37 Billion | -$93.17 Million | 0.16x | N/A |
| 2024 | $1.46 Billion | $9.79 Billion | $601.18 Million | 0.15x | 2.42x |
| 2025 | $1.73 Billion | $10.55 Billion | $540.71 Million | 0.16x | 3.21x |
Competitor Companies of 600267 by Market Capitalization
Companies near Zhejiang Hisun Pharmaceutical Co Ltd in the global market cap rankings as of September 16, 2026. Review 600267 tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Zhejiang Hisun Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Zhejiang Hisun Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Zhejiang Hisun Pharmaceutical Co Ltd's market cap moved from $2.66 Billion to $ 1.98 Billion, with a yearly change of -1.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.98 Billion | +14.26% |
| 2025 | CN¥1.73 Billion | +19.16% |
| 2024 | CN¥1.46 Billion | -11.32% |
| 2023 | CN¥1.64 Billion | -13.87% |
| 2022 | CN¥1.91 Billion | -20.45% |
| 2021 | CN¥2.40 Billion | -15.06% |
| 2020 | CN¥2.82 Billion | +67.34% |
| 2019 | CN¥1.69 Billion | +18.12% |
| 2018 | CN¥1.43 Billion | -44.41% |
| 2017 | CN¥2.57 Billion | +15.62% |
| 2016 | CN¥2.22 Billion | -16.52% |
| 2015 | CN¥2.66 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Zhejiang Hisun Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.98 Billion USD |
| MoneyControl | $1.98 Billion USD |
| MarketWatch | $1.98 Billion USD |
| marketcap.company | $1.98 Billion USD |
| Reuters | $1.98 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Hisun Pharmaceutical Co Ltd
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small mol… Read more